Gabapentin Market Report

Europe Gabapentin Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 20, 2020
  • PAGES：164
  • REPORT CODE：GMM566308
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Gabapentin market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.9% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Gabapentin Market Segmentations:

    By Player:

    • Actavis

    • Sailike

    • Glenmark

    • GSK

    • Novartis

    • Pfizer

    • Jiangsu Enhua

    • Jiangsu Hengrui

    By Type:

    • Tablet

    • Capsule

    By End-User:

    • Nerve Pain

    • Restless Legs Syndrome

    • Seizures

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gabapentin Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Gabapentin Market Size and Growth Rate of Tablet from 2014 to 2026

    • 1.3.2 Europe Gabapentin Market Size and Growth Rate of Capsule from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Gabapentin Market Size and Growth Rate of Nerve Pain from 2014 to 2026

    • 1.4.2 Europe Gabapentin Market Size and Growth Rate of Restless Legs Syndrome from 2014 to 2026

    • 1.4.3 Europe Gabapentin Market Size and Growth Rate of Seizures from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Gabapentin Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Gabapentin Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Gabapentin Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Gabapentin Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Gabapentin Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Gabapentin Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Gabapentin Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Gabapentin Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Gabapentin Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gabapentin Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Gabapentin Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Gabapentin Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Gabapentin Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Gabapentin by Major Types

      • 3.4.1 Market Size and Growth Rate of Tablet

      • 3.4.2 Market Size and Growth Rate of Capsule

    4 Segmentation of Gabapentin Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Gabapentin by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Nerve Pain for Construction

      • 4.4.2 Market Size and Growth Rate of Restless Legs Syndrome for Construction

      • 4.4.3 Market Size and Growth Rate of Seizures for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Gabapentin Production Analysis by Top Regions

    • 5.2 Europe Gabapentin Consumption Analysis by Top Regions

    • 5.3 Europe Gabapentin Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Gabapentin Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Gabapentin Production, Import, Consumption and Export Analysis

      • 5.3.3 France Gabapentin Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Gabapentin Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Gabapentin Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Gabapentin Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Gabapentin Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Gabapentin Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Gabapentin Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gabapentin Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Gabapentin Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Gabapentin Production, Import, Consumption and Export Analysis

    6 Product Circulation of Gabapentin Market among Top Countries

    • 6.1 Top 5 Export Countries in Gabapentin Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Gabapentin Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Gabapentin Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Gabapentin Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Gabapentin Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Gabapentin Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Gabapentin Landscape Analysis

    • 7.1 Germany Gabapentin Landscape Analysis by Major Types

    • 7.2 Germany Gabapentin Landscape Analysis by Major End-Users

    8. UK Gabapentin Landscape Analysis

    • 8.1 UK Gabapentin Landscape Analysis by Major Types

    • 8.2 UK Gabapentin Landscape Analysis by Major End-Users

    9. France Gabapentin Landscape Analysis

    • 9.1 France Gabapentin Landscape Analysis by Major Types

    • 9.2 France Gabapentin Landscape Analysis by Major End-Users

    10. Italy Gabapentin Landscape Analysis

    • 10.1 Italy Gabapentin Landscape Analysis by Major Types

    • 10.2 Italy Gabapentin Landscape Analysis by Major End-Users

    11. Spain Gabapentin Landscape Analysis

    • 11.1 Spain Gabapentin Landscape Analysis by Major Types

    • 11.2 Spain Gabapentin Landscape Analysis by Major End-Users

    12. Poland Gabapentin Landscape Analysis

    • 12.1 Poland Gabapentin Landscape Analysis by Major Types

    • 12.2 Poland Gabapentin Landscape Analysis by Major End-Users

    13. Russia Gabapentin Landscape Analysis

    • 13.1 Russia Gabapentin Landscape Analysis by Major Types

    • 13.2 Russia Gabapentin Landscape Analysis by Major End-Users

    14. Switzerland Gabapentin Landscape Analysis

    • 14.1 Switzerland Gabapentin Landscape Analysis by Major Types

    • 14.2 Switzerland Gabapentin Landscape Analysis by Major End-Users

    15. Turkey Gabapentin Landscape Analysis

    • 15.1 Turkey Gabapentin Landscape Analysis by Major Types

    • 15.2 Turkey Gabapentin Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gabapentin Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gabapentin Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gabapentin Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gabapentin Landscape Analysis by Top Countries

      • 16.3.1 Denmark Gabapentin Market Volume and Growth Rate

      • 16.3.2 Finland Gabapentin Market Volume and Growth Rate

      • 16.3.3 Norway Gabapentin Market Volume and Growth Rate

      • 16.3.4 Sweden Gabapentin Market Volume and Growth Rate

      • 16.3.6 Iceland Gabapentin Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Gabapentin Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Gabapentin Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Gabapentin Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Gabapentin Landscape Analysis by Top Countries

      • 17.3.1 Belgium Gabapentin Market Volume and Growth Rate

      • 17.3.2 Netherlands Gabapentin Market Volume and Growth Rate

      • 17.3.3 Luxembourg Gabapentin Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Gabapentin Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Gabapentin Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Gabapentin Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Gabapentin Landscape Analysis by Top Countries

      • 18.3.1 Estonia Gabapentin Market Volume and Growth Rate

      • 18.3.2 Latvia Gabapentin Market Volume and Growth Rate

      • 18.3.3 Lithuania Gabapentin Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Actavis

      • 19.1.1 Actavis Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Sailike

      • 19.2.1 Sailike Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Glenmark

      • 19.3.1 Glenmark Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 GSK

      • 19.4.1 GSK Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Novartis

      • 19.5.1 Novartis Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Pfizer

      • 19.6.1 Pfizer Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Jiangsu Enhua

      • 19.7.1 Jiangsu Enhua Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Jiangsu Hengrui

      • 19.8.1 Jiangsu Hengrui Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    The List of Tables and Figures (Totals 78 Figures and 191 Tables)

    • Figure Product Picture

    • Figure Gabapentin Market Size and Growth Rate of Tablet Market, 2015 - 2026 (USD Million)

    • Figure Gabapentin Market Size and Growth Rate of Capsule Market, 2015 - 2026 (USD Million)

    • Figure Gabapentin Market Size and Growth Rate of Nerve Pain from 2014 to 2026

    • Figure Gabapentin Market Size and Growth Rate of Restless Legs Syndrome from 2014 to 2026

    • Figure Gabapentin Market Size and Growth Rate of Seizures from 2014 to 2026

    • Figure Germany Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure UK Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure France Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Gabapentin Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Gabapentin Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Gabapentin

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Gabapentin by Different Types from 2014 to 2026

    • Table Consumption Share of Gabapentin by Different Types from 2014 to 2026

    • Figure Gabapentin Market Size and Growth Rate of Tablet Market, 2015 - 2026 (USD Million)

    • Figure Gabapentin Market Size and Growth Rate of Capsule Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Gabapentin by Different End-Users from 2014 to 2026

    • Table Consumption Share of Gabapentin by Different End-Users from 2014 to 2026

    • Figure Gabapentin Market Size and Growth Rate of Nerve Pain from 2014 to 2026

    • Figure Gabapentin Market Size and Growth Rate of Restless Legs Syndrome from 2014 to 2026

    • Figure Gabapentin Market Size and Growth Rate of Seizures from 2014 to 2026

    • Table Europe Gabapentin Production by Major Regions

    • Table Europe Gabapentin Production Share by Major Regions

    • Figure Europe Gabapentin Production Share by Major Countries and Regions in 2014

    • Table Europe Gabapentin Consumption by Major Regions

    • Table Europe Gabapentin Consumption Share by Major Regions

    • Table Germany Gabapentin Production, Import, Consumption and Export Analysis

    • Table UK Gabapentin Production, Import, Consumption and Export Analysis

    • Table France Gabapentin Production, Import, Consumption and Export Analysis

    • Table Italy Gabapentin Production, Import, Consumption and Export Analysis

    • Table Spain Gabapentin Production, Import, Consumption and Export Analysis

    • Table Poland Gabapentin Production, Import, Consumption and Export Analysis

    • Table Russia Gabapentin Production, Import, Consumption and Export Analysis

    • Table Switzerland Gabapentin Production, Import, Consumption and Export Analysis

    • Table Turkey Gabapentin Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gabapentin Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gabapentin Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gabapentin Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Gabapentin Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Gabapentin Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Gabapentin Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Gabapentin Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Gabapentin Consumption by Types from 2014 to 2026

    • Table Germany Gabapentin Consumption Share by Types from 2014 to 2026

    • Table Germany Gabapentin Consumption by End-Users from 2014 to 2026

    • Table Germany Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Table UK Gabapentin Consumption by Types from 2014 to 2026

    • Table UK Gabapentin Consumption Share by Types from 2014 to 2026

    • Table UK Gabapentin Consumption by End-Users from 2014 to 2026

    • Table UK Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Table France Gabapentin Consumption by Types from 2014 to 2026

    • Table France Gabapentin Consumption Share by Types from 2014 to 2026

    • Table France Gabapentin Consumption by End-Users from 2014 to 2026

    • Table France Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Table Italy Gabapentin Consumption by Types from 2014 to 2026

    • Table Italy Gabapentin Consumption Share by Types from 2014 to 2026

    • Table Italy Gabapentin Consumption by End-Users from 2014 to 2026

    • Table Italy Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Table Spain Gabapentin Consumption by Types from 2014 to 2026

    • Table Spain Gabapentin Consumption Share by Types from 2014 to 2026

    • Table Spain Gabapentin Consumption by End-Users from 2014 to 2026

    • Table Spain Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Table Poland Gabapentin Consumption by Types from 2014 to 2026

    • Table Poland Gabapentin Consumption Share by Types from 2014 to 2026

    • Table Poland Gabapentin Consumption by End-Users from 2014 to 2026

    • Table Poland Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Table Russia Gabapentin Consumption by Types from 2014 to 2026

    • Table Russia Gabapentin Consumption Share by Types from 2014 to 2026

    • Table Russia Gabapentin Consumption by End-Users from 2014 to 2026

    • Table Russia Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Gabapentin Consumption by Types from 2014 to 2026

    • Table Switzerland Gabapentin Consumption Share by Types from 2014 to 2026

    • Table Switzerland Gabapentin Consumption by End-Users from 2014 to 2026

    • Table Switzerland Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Gabapentin Consumption by Types from 2014 to 2026

    • Table Turkey Gabapentin Consumption Share by Types from 2014 to 2026

    • Table Turkey Gabapentin Consumption by End-Users from 2014 to 2026

    • Table Turkey Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gabapentin Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gabapentin Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gabapentin Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gabapentin Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gabapentin Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gabapentin Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gabapentin Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gabapentin Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gabapentin Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gabapentin Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gabapentin Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gabapentin Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gabapentin Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gabapentin Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gabapentin Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Table Actavis Profiles

    • Table Actavis Production, Value, Price, Gross Margin 2014-2019

    • Table Actavis Product benchmarking

    • Table Actavis Strategic initiatives

    • Table Actavis SWOT analysis

    • Table Sailike Profiles

    • Table Sailike Production, Value, Price, Gross Margin 2014-2019

    • Table Sailike Product benchmarking

    • Table Sailike Strategic initiatives

    • Table Sailike SWOT analysis

    • Table Glenmark Profiles

    • Table Glenmark Production, Value, Price, Gross Margin 2014-2019

    • Table Glenmark Product benchmarking

    • Table Glenmark Strategic initiatives

    • Table Glenmark SWOT analysis

    • Table GSK Profiles

    • Table GSK Production, Value, Price, Gross Margin 2014-2019

    • Table GSK Product benchmarking

    • Table GSK Strategic initiatives

    • Table GSK SWOT analysis

    • Table Novartis Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Novartis Product benchmarking

    • Table Novartis Strategic initiatives

    • Table Novartis SWOT analysis

    • Table Pfizer Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Pfizer Product benchmarking

    • Table Pfizer Strategic initiatives

    • Table Pfizer SWOT analysis

    • Table Jiangsu Enhua Profiles

    • Table Jiangsu Enhua Production, Value, Price, Gross Margin 2014-2019

    • Table Jiangsu Enhua Product benchmarking

    • Table Jiangsu Enhua Strategic initiatives

    • Table Jiangsu Enhua SWOT analysis

    • Table Jiangsu Hengrui Profiles

    • Table Jiangsu Hengrui Production, Value, Price, Gross Margin 2014-2019

    • Table Jiangsu Hengrui Product benchmarking

    • Table Jiangsu Hengrui Strategic initiatives

    • Table Jiangsu Hengrui SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US